{
  "doc_id": "Balo-Disease",
  "doc_filename": "Balo-Disease.pdf",
  "top_entities": [
    {
      "name": "autoimmune disorder",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "infectious disease",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "corticosteroids",
      "mention_count": 1,
      "entity_type": "drug"
    }
  ],
  "file_size_bytes": 2303,
  "file_size_human": "2.2 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "CRM",
  "document_type_name": "Clinical Research Materials",
  "document_type_group": "Clinical Research Materials",
  "classification_confidence": 0.15,
  "title": "Balo Disease: Clinical Overview and Treatment Approaches",
  "short_description": "Clinical document describing Balo Disease, a rare variant of multiple sclerosis, including its symptoms, potential autoimmune causes, and treatment options.",
  "long_description": "This clinical document provides a comprehensive overview of Balo Disease, a rare neurological disorder that is considered a variant of multiple sclerosis. The document details the gradual onset of symptoms including muscle spasms, paralysis, and various neurological manifestations depending on affected brain areas. It discusses the potential autoimmune etiology of the condition, noting that while the exact cause remains unknown, autoimmune factors may contribute to its development. The document highlights the geographic distribution of cases, with higher prevalence reported in China and the Philippines, and outlines current treatment approaches including corticosteroids for acute presentations and symptomatic management through pharmacologic and rehabilitative interventions.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T07:47:57.887155"
}